Senior Vice President, Discovery & Platform Development
New York Stem Cell Foundation (NYSCF)
Dr. Daniel Paull is Senior Vice President, Discovery and Platform Development at the NYSCF Research Institute. Daniel oversees the NYSCF Global Stem Cell Array®, an automated platform for large scale derivation, genome editing and differentiation of human induced pluripotent stem cells. Combining biology, software and hardware engineering, this platform has generated thousands of stem cell lines both within collaborations and as a community resource through the NYSCF Cell Line Repository. He is currently leading efforts to develop novel approaches for detecting disease signatures and identifying therapeutic candidates to treat a range of diseases including Parkinson’s disease, multiple sclerosis, and rare diseases. Prior to joining this platform, while based in the laboratory of Professor Dieter Egli, he led the development of a novel technique to prevent the inheritance of mitochondria disease using IVF-type approaches. Daniel was also heavily involved in developing techniques to derive human cell lines using somatic cell nuclear transfer and develop models of diabetes using iPSCs. Daniel obtained his PhD from University College London.